RACHAEL YOUNG: Open Payments
NPI 1598291841 · BAYTOWN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$201 in 10 payments from 9 companies in 2025. Trend: 2023 $496 · 2024 $762 · 2025 $201
Food & beverage: $201
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 2 | $51 |
| Lilly USA, LLC | 1 | $28 |
| GlaxoSmithKline, LLC. | 1 | $25 |
| Astellas Pharma US Inc | 1 | $20 |
| TAIHO ONCOLOGY, INC. | 1 | $17 |
| Genmab U.S., Inc. | 1 | $16 |
| Karyopharm Therapeutics Inc. | 1 | $15 |
| Spectrum Pharmaceuticals Inc. | 1 | $15 |
| RECORDATI_RARE_DISEASES_INC. | 1 | $14 |
Products named: VERZENIO, KEYTRUDA, OJJAARA, LYNPARZA, Xtandi, LONSURF, Epkinly, XPOVIO.
Industry payments across TX — which companies pay providers there.
